Ісландія -
ісландська -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 0,5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 0,5 mg
Ісландія -
ісландська -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 1 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 1 mg
Ісландія -
ісландська -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 5 mg
Ісландія -
ісландська -
LYFJASTOFNUN (Icelandic Medicines Agency)
quetiapin medical valley forðatafla 300 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 300 mg
Ісландія -
ісландська -
LYFJASTOFNUN (Icelandic Medicines Agency)
quetiapin medical valley forðatafla 150 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 150 mg
Ісландія -
ісландська -
LYFJASTOFNUN (Icelandic Medicines Agency)
quetiapin medical valley forðatafla 50 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 50 mg
Ісландія -
ісландська -
LYFJASTOFNUN (Icelandic Medicines Agency)
quetiapin medical valley forðatafla 200 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 200 mg
Ісландія -
ісландська -
LYFJASTOFNUN (Icelandic Medicines Agency)
quetiapin medical valley forðatafla 400 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 400 mg
Європейський Союз -
ісландська -
EMA (European Medicines Agency)
efmody
diurnal europe b.v. - hýdrókortisón - adrenal hyperplasia, congenital - barksterar til almennrar notkunar - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.
Ісландія -
ісландська -
LYFJASTOFNUN (Icelandic Medicines Agency)
albuman innrennslislyf, lausn 200 g/l
prothya biosolutions netherlands b.v. - human serum albumin - innrennslislyf, lausn - 200 g/l